Calidi Biotherapeutics, Inc. — All Filings
376 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
25
25-NSE
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001641172-25-018553 | Jul 10, 2025 | Jul 9, 2025 |
| 424B3 | 424B3 | 0001641172-25-018556 | Jul 10, 2025 | — |
| 424B3 | 424B3 | 0001641172-25-018557 | Jul 10, 2025 | — |
| CORRESP | — | 0001641172-25-018566 | Jul 10, 2025 | — |
| UPLOAD | — | 0000000000-25-007155 | Jul 8, 2025 | — |
| UPLOAD | — | 0000000000-25-007156 | Jul 8, 2025 | — |
| S-1 | S-1 | 0001641172-25-017875 | Jul 3, 2025 | — |
| DRS | — | 0001641172-25-017600 | Jul 2, 2025 | — |
| DEF 14A | DEF 14A | 0001641172-25-012252 | May 23, 2025 | — |
| DEFA14A | DEFA14A | 0001641172-25-012253 | May 23, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-002220 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-010317 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001641172-25-010348 | May 14, 2025 | — |
| PRE 14A | PRE 14A | 0001641172-25-009711 | May 12, 2025 | — |
| 8-K | 8-K | 0001641172-25-008365 | May 2, 2025 | Apr 30, 2025 |
| 3 | — | 0001641172-25-006062 | Apr 25, 2025 | Apr 22, 2025 |
| 4 | — | 0001641172-25-006070 | Apr 25, 2025 | Apr 22, 2025 |
| 8-K | — | 0001641172-25-005777 | Apr 23, 2025 | Apr 17, 2025 |
| 8-K | — | 0001641172-25-003501 | Apr 10, 2025 | Apr 8, 2025 |
| 8-K | — | 0001641172-25-001969 | Apr 1, 2025 | Mar 28, 2025 |
| 424B5 | — | 0001641172-25-001350 | Mar 31, 2025 | — |
| 10-K | — | 0001641172-25-001810 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K | — | 0001641172-25-001822 | Mar 31, 2025 | — |
| 8-K | — | 0001493152-25-009731 | Mar 10, 2025 | — |
| 8-K/A | — | 0001493152-25-005699 | Feb 10, 2025 | — |
| EFFECT | — | 9999999995-25-000352 | Feb 7, 2025 | — |
| CORRESP | — | 0001493152-25-005084 | Feb 6, 2025 | — |
| 8-K | — | 0001493152-25-004887 | Feb 5, 2025 | Feb 4, 2025 |
| 424B5 | — | 0001493152-25-004885 | Feb 5, 2025 | — |
| 8-K | — | 0001493152-25-003916 | Jan 28, 2025 | Jan 23, 2025 |
| UPLOAD | — | 0000000000-25-000432 | Jan 15, 2025 | — |
| 424B5 | — | 0001493152-25-001565 | Jan 10, 2025 | — |
| S-3 | — | 0001493152-25-001755 | Jan 10, 2025 | — |
| 8-K | — | 0001493152-25-001567 | Jan 10, 2025 | Jan 8, 2025 |
| 8-K | — | 0001493152-25-001711 | Jan 10, 2025 | — |
| 424B5 | — | 0001493152-25-001382 | Jan 8, 2025 | — |
| 4 | — | 0001493152-25-000302 | Jan 3, 2025 | Dec 31, 2024 |
| 4 | — | 0001493152-25-000306 | Jan 3, 2025 | Dec 31, 2024 |
| EFFECT | — | 9999999995-24-003933 | Dec 27, 2024 | — |
| CORRESP | — | 0001493152-24-052065 | Dec 26, 2024 | — |
| 4 | — | 0001493152-24-050675 | Dec 18, 2024 | Dec 17, 2024 |
| UPLOAD | — | 0000000000-24-013920 | Dec 17, 2024 | — |
| S-1 | — | 0001493152-24-049670 | Dec 12, 2024 | — |
| 424B5 | — | 0001493152-24-048189 | Nov 29, 2024 | — |
| 8-K | — | 0001493152-24-046434 | Nov 18, 2024 | — |
| 8-K | — | 0001493152-24-046330 | Nov 15, 2024 | Nov 14, 2024 |
| 424B5 | — | 0001493152-24-046144 | Nov 15, 2024 | — |
| SC 13G/A | CALIDI BIOTHERAPEUTICS, INC. | 0001326389-24-000189 | Nov 14, 2024 | — |
| 424B5 | — | 0001493152-24-045268 | Nov 14, 2024 | — |
| 8-K | — | 0001493152-24-044932 | Nov 13, 2024 | Nov 12, 2024 |